When a research peptide is described as 99% purity, it means that when a sample was run through an HPLC system, 99% of the total detected peak area belonged to the target peptide and 1% belonged to everything else that absorbed UV light. It is a relative measure of quality, not a measure of quantity, and it says nothing about water, salts, or bacterial endotoxins. Understanding what peptide purity does and does not capture is the difference between reading a certificate of analysis and being reassured by one.
What 99% peptide purity means on a COA
Synthetic peptides are made by joining amino acids one at a time on a solid support, a process called solid-phase peptide synthesis. Each coupling step is highly efficient but not perfect, so a small fraction of chains miss a residue, gain an unwanted modification, or stop growing early. After synthesis, the crude product is purified, usually by preparative HPLC, to remove as many of those by-products as possible. The purity figure describes how successful that clean-up was.
For a 30-residue peptide such as a GLP-1 analogue, even a 99.5% per-step efficiency would leave a crude product that is only about 86% full-length chains before purification. That is why purification matters so much, and why a purity figure on the finished material is the single most quoted quality metric in the sector. Calibre pens target above 99% purity on every batch, verified by Janoshik Analytical.
How HPLC measures peptide purity
High-performance liquid chromatography pumps the dissolved sample through a column packed with tiny silica particles coated in a hydrophobic chain, most often C18. A gradient of water and acetonitrile flows through the column, and each component of the sample is held back by the coating for a different length of time depending on how hydrophobic it is. As each component leaves the column, a UV detector, typically set around 214 or 220 nanometres where the peptide bond absorbs, records a peak.
The software then integrates the area under every peak. Purity is the area of the main peak divided by the sum of all peak areas. A related impurity, such as a chain missing one amino acid, usually elutes very close to the main compound; a good method resolves it as a separate shoulder or peak so it is counted against purity rather than hidden inside it.
Why the method matters
The same sample can return different purity figures on different methods. A short, steep gradient may merge closely related peaks and flatter the result; a long, shallow gradient separates them and gives a more honest figure. This is one reason independent testing at a lab that uses a consistent, documented method is more informative than a manufacturer figure with no method stated.
What HPLC purity cannot see
The UV detector only records molecules that absorb light at the chosen wavelength. Several things that are present in every lyophilised peptide do not, and so are invisible to the purity calculation.
- Water: freeze-dried peptides are hygroscopic and commonly hold several percent water by weight.
- Counter-ions: peptides are usually supplied as trifluoroacetate (TFA) or acetate salts, and the counter-ion can account for 5 to 15% of the powder mass.
- Inorganic salts left over from purification and buffer exchange.
- Bacterial endotoxins, which are lipopolysaccharide fragments that do not chromatograph like peptides.
- Non-UV-absorbing contaminants such as some solvents.
This is why a vial labelled 10 mg and tested at 99% purity does not necessarily contain 9.9 mg of peptide. The powder may be 99% pure by HPLC but only 75 to 85% peptide by mass once water and counter-ions are accounted for. The figure that captures this is net peptide content, and it comes from a different test, usually amino acid analysis or a quantitative UV or HPLC assay against a reference standard.
Mass spectrometry: identity, not purity
HPLC answers the question "how much of this sample is one compound?" It does not answer "which compound?" A 99% pure sample of the wrong peptide is still the wrong peptide. Mass spectrometry closes that gap by ionising the sample and measuring the mass-to-charge ratio of the ions, from which the molecular weight is calculated and compared with the theoretical value for the declared sequence.
Most testing labs couple the two techniques as LC-MS, so the compound eluting as the main peak is the one whose mass is measured. On a Janoshik report you will see the expected molecular weight, the observed value and a statement of whether identity was confirmed. Because larger peptides pick up multiple charges, the raw spectrum shows several peaks that the software deconvolutes to a single mass. A match within a fraction of a Dalton confirms the sequence length and composition, though it cannot on its own distinguish between two sequences with the same amino acids in a different order.
Endotoxins and the LAL test
Endotoxins are fragments of the outer membrane of Gram-negative bacteria. They survive filtration and heat that would kill the bacteria themselves, so a product can be sterile and still carry endotoxin from water, glassware or process equipment. They are biologically active at extremely low concentrations, which is why regulators set limits for licensed injectable medicines and why research labs working with cell or animal models care about them.
The standard assay is the Limulus amebocyte lysate (LAL) test, which uses a reagent derived from horseshoe crab blood cells that clots or changes colour in the presence of endotoxin. Results are reported in endotoxin units (EU) per milligram or per millilitre. Newer recombinant factor C assays measure the same thing without animal-derived reagent and are increasingly accepted.
| Test | Question it answers | Typical unit | What it misses |
|---|---|---|---|
| HPLC purity | How much of the detectable material is one compound? | Percent (area) | Identity, water, salts, endotoxins |
| Mass spectrometry | Is the main compound the declared peptide? | Daltons (observed vs expected) | Purity, quantity, sequence order |
| Net peptide content | How much actual peptide is in the powder by mass? | Percent (w/w) or mg | Impurity profile |
| Endotoxin (LAL) | Is there bacterial endotoxin present? | EU/mg or EU/ml | Chemical purity and identity |
| Sterility / bioburden | Are viable microorganisms present? | Pass/fail or CFU | Endotoxin from dead bacteria |
Purity versus quantity: the net peptide content trap
The most common misunderstanding in the sector is treating purity as a statement of how much peptide you received. It is not. Two suppliers can both truthfully advertise 99% purity while one delivers a vial with 30% less actual peptide than the other, simply because of differences in water content, counter-ion and fill accuracy.
For a pre-filled pen, the equivalent check is a quantitative assay of the finished solution against the labelled concentration. This is harder to fake than a purity figure on raw powder, because it tests the product as sold. When a supplier publishes both a purity result and a content result for the same batch number, you are looking at a far more complete picture than a purity percentage alone.
Three questions to ask of any purity claim
Which lab produced the figure and can the report be verified? Does the report show the chromatogram, not just the headline? Is there a separate content or quantitative result for the batch? If the answer to all three is yes, the 99% means something.
Why the last one percent matters in research
The difference between 95% and 99% purity sounds small, but the impurities are not random. They are structurally related to the target peptide: deletion sequences missing a residue, truncated chains, oxidised methionine variants, deamidated asparagine, or chains still carrying a protecting group. In a cell assay or animal model these related compounds can bind the same receptors with different affinity, or provoke an immune response, and they confound results in ways that are difficult to trace afterwards.
In the published literature, purity thresholds are routinely stated in the methods section precisely because reviewers know this. Research suggests that impurity profiles, not just the headline number, are what determine whether a batch behaves like the reference material. A 99% result from a well-resolved HPLC method with confirmed identity is a reasonable proxy for that, which is why it has become the benchmark buyers look for.
Research use only
Purity, identity and endotoxin results describe the chemistry of a research sample. They are not a safety approval and do not make any product suitable for administration. All Calibre products are sold for laboratory research use only. Not for human consumption.
How Calibre approaches purity
Every Calibre batch is sent to Janoshik Analytical for independent HPLC purity and mass-spectrometry identity testing, with a target of above 99% purity. The report for each batch is published on our COA page with its verification ID, so buyers can confirm the result with the lab rather than with us. If you want the report for a specific batch before ordering, contact us by WhatsApp, Telegram or email at sales@calibre-pens.co.uk and we will send the link.
Browse Calibre research pens
Every batch is independently tested and the certificate of analysis is published on our COA page. Precision-made pre-filled pens from a UK-based supplier.
Frequently asked questions
This article is provided for educational purposes and reports published research. It is not medical advice. All Calibre products are supplied for laboratory research use only and are not for human consumption.
